Active Not RecruitingNCT07336238
Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies
Medication studyAges 18–85United States
Understand this study
Who could participate?
Listed age limits: 18 years to 85 years.
- Listed locations
- SeattleSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 19, 2026
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 16
- Sponsor
- University of Washington
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug, OTHER
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 85 Years
- Official registry ID
- NCT07336238
- Official title
Show the full official title
A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and Depression
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Seattle
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Washington, a university.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin.
Who can participate?
Listed age limits: 18 years to 85 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
